Clinical and laboratory characteristics of the patterns of chronic kidney disease in patients with type 2 diabetes

BACKGROUND: A growing body of evidence demonstrates increasing prevalence of normoalbuminuric chronic kidney disease (NA-CKD) in subjects with type 2 diabetes (T2D), while proportion of albuminuric pattern is decreasing. AIMS: To determine the clinical and laboratory parameters associated with diff...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vadim V. Klimontov, Anton I. Korbut, Olga N. Fazullina, Ilya V. Vinogradov, Vyacheslav V. Romanov
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2019
Materias:
Acceso en línea:https://doaj.org/article/61d9f3457c714d6182d2aed91caa542f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:61d9f3457c714d6182d2aed91caa542f
record_format dspace
spelling oai:doaj.org-article:61d9f3457c714d6182d2aed91caa542f2021-11-14T09:00:22ZClinical and laboratory characteristics of the patterns of chronic kidney disease in patients with type 2 diabetes2072-03512072-037810.14341/DM10277https://doaj.org/article/61d9f3457c714d6182d2aed91caa542f2019-12-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/10277https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378BACKGROUND: A growing body of evidence demonstrates increasing prevalence of normoalbuminuric chronic kidney disease (NA-CKD) in subjects with type 2 diabetes (T2D), while proportion of albuminuric pattern is decreasing. AIMS: To determine the clinical and laboratory parameters associated with different patterns of CKD in patients with T2D. METHODS: This observational, single-center, cross-sectional study included 360 patients with T2D duration ≥10 years. Patients with urinary albumin/creatinine ratio (UACR) <3 mg/mmol and estimated glomerular filtration rate (eGFR) >60 ml/min/1.73 m2 were classified as no-CKD group (n=89). Patients with UACR <3 mg/mmol and eGFR <60 ml/min/1.73 m2 formed NA-CKD group (n=111). Individuals with eGFR ≥60 ml/min/1.73 m2 and UACR mg/mmol ≥3 were recorded as albuminuric with preserved renal function (A-CKD–, n=87). Patients with eGFR <60 ml/min/1.73 m2 and UACR mg/mmol ≥3 mg/mmol were considered as albuminuric CKD group (A-CKD+, n=73). Urinary nephrin and podocin, the podocyte injury markers, and whey acidic protein four-disulfide core domain protein 2 (WFDC-2), a marker of tubulointerstitial involvement, was assessed by ELISA and compared to control (20 non-diabetic subjects). RESULTS: Age ≥65 years (p=0.0001), duration of T2D ≥15 years (p=0.0009), female sex (p=0.04), and therapy with diuretics (p=0.0005) were found as risk factors for NA-CKD. The risk factors for A-CKD were male sex (p=0.01), smoking (p=0.01), waist-to-hip ratio >1 (p=0.01) and HbA1c levels >8% (p=0.005). The duration of T2D ≥15 years (p=0.01) and the use of dihydropyridine calcium channel blockers (p=0.01) were associated with A-CKD+. In T2D groups, the urinary excretion of nephrin and podocin was increased (all p<0.001), more markedly in albuminuric individuals (p<0.01 vs. NA-CKD). WFDC-2 excretion was increased in men from all diabetic groups (p<0.05) and in women with decreased eGFR only (p<0.05 vs. the control and NA-CKD). CONCLUSIONS: The CKD patterns in T2D are heterogeneous according to their clinical and laboratory characteristics. The changes in the excretion of nephrin and podocin indicate the association of albuminuric patterns with podocyte injury. A decrease in eGFR in women with T2D is associated with an increase in urinary excretion of WFDC-2, tubulointerstitial fibrosis marker.Vadim V. KlimontovAnton I. KorbutOlga N. FazullinaIlya V. VinogradovVyacheslav V. RomanovEndocrinology Research Centrearticlediabeteschronic kidney diseasepodocytesalbuminuriaglomerular filtration rateNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 22, Iss 6, Pp 515-525 (2019)
institution DOAJ
collection DOAJ
language EN
RU
topic diabetes
chronic kidney disease
podocytes
albuminuria
glomerular filtration rate
Nutritional diseases. Deficiency diseases
RC620-627
spellingShingle diabetes
chronic kidney disease
podocytes
albuminuria
glomerular filtration rate
Nutritional diseases. Deficiency diseases
RC620-627
Vadim V. Klimontov
Anton I. Korbut
Olga N. Fazullina
Ilya V. Vinogradov
Vyacheslav V. Romanov
Clinical and laboratory characteristics of the patterns of chronic kidney disease in patients with type 2 diabetes
description BACKGROUND: A growing body of evidence demonstrates increasing prevalence of normoalbuminuric chronic kidney disease (NA-CKD) in subjects with type 2 diabetes (T2D), while proportion of albuminuric pattern is decreasing. AIMS: To determine the clinical and laboratory parameters associated with different patterns of CKD in patients with T2D. METHODS: This observational, single-center, cross-sectional study included 360 patients with T2D duration ≥10 years. Patients with urinary albumin/creatinine ratio (UACR) <3 mg/mmol and estimated glomerular filtration rate (eGFR) >60 ml/min/1.73 m2 were classified as no-CKD group (n=89). Patients with UACR <3 mg/mmol and eGFR <60 ml/min/1.73 m2 formed NA-CKD group (n=111). Individuals with eGFR ≥60 ml/min/1.73 m2 and UACR mg/mmol ≥3 were recorded as albuminuric with preserved renal function (A-CKD–, n=87). Patients with eGFR <60 ml/min/1.73 m2 and UACR mg/mmol ≥3 mg/mmol were considered as albuminuric CKD group (A-CKD+, n=73). Urinary nephrin and podocin, the podocyte injury markers, and whey acidic protein four-disulfide core domain protein 2 (WFDC-2), a marker of tubulointerstitial involvement, was assessed by ELISA and compared to control (20 non-diabetic subjects). RESULTS: Age ≥65 years (p=0.0001), duration of T2D ≥15 years (p=0.0009), female sex (p=0.04), and therapy with diuretics (p=0.0005) were found as risk factors for NA-CKD. The risk factors for A-CKD were male sex (p=0.01), smoking (p=0.01), waist-to-hip ratio >1 (p=0.01) and HbA1c levels >8% (p=0.005). The duration of T2D ≥15 years (p=0.01) and the use of dihydropyridine calcium channel blockers (p=0.01) were associated with A-CKD+. In T2D groups, the urinary excretion of nephrin and podocin was increased (all p<0.001), more markedly in albuminuric individuals (p<0.01 vs. NA-CKD). WFDC-2 excretion was increased in men from all diabetic groups (p<0.05) and in women with decreased eGFR only (p<0.05 vs. the control and NA-CKD). CONCLUSIONS: The CKD patterns in T2D are heterogeneous according to their clinical and laboratory characteristics. The changes in the excretion of nephrin and podocin indicate the association of albuminuric patterns with podocyte injury. A decrease in eGFR in women with T2D is associated with an increase in urinary excretion of WFDC-2, tubulointerstitial fibrosis marker.
format article
author Vadim V. Klimontov
Anton I. Korbut
Olga N. Fazullina
Ilya V. Vinogradov
Vyacheslav V. Romanov
author_facet Vadim V. Klimontov
Anton I. Korbut
Olga N. Fazullina
Ilya V. Vinogradov
Vyacheslav V. Romanov
author_sort Vadim V. Klimontov
title Clinical and laboratory characteristics of the patterns of chronic kidney disease in patients with type 2 diabetes
title_short Clinical and laboratory characteristics of the patterns of chronic kidney disease in patients with type 2 diabetes
title_full Clinical and laboratory characteristics of the patterns of chronic kidney disease in patients with type 2 diabetes
title_fullStr Clinical and laboratory characteristics of the patterns of chronic kidney disease in patients with type 2 diabetes
title_full_unstemmed Clinical and laboratory characteristics of the patterns of chronic kidney disease in patients with type 2 diabetes
title_sort clinical and laboratory characteristics of the patterns of chronic kidney disease in patients with type 2 diabetes
publisher Endocrinology Research Centre
publishDate 2019
url https://doaj.org/article/61d9f3457c714d6182d2aed91caa542f
work_keys_str_mv AT vadimvklimontov clinicalandlaboratorycharacteristicsofthepatternsofchronickidneydiseaseinpatientswithtype2diabetes
AT antonikorbut clinicalandlaboratorycharacteristicsofthepatternsofchronickidneydiseaseinpatientswithtype2diabetes
AT olganfazullina clinicalandlaboratorycharacteristicsofthepatternsofchronickidneydiseaseinpatientswithtype2diabetes
AT ilyavvinogradov clinicalandlaboratorycharacteristicsofthepatternsofchronickidneydiseaseinpatientswithtype2diabetes
AT vyacheslavvromanov clinicalandlaboratorycharacteristicsofthepatternsofchronickidneydiseaseinpatientswithtype2diabetes
_version_ 1718429531485765632